412 related articles for article (PubMed ID: 27698942)
1. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
[No Abstract] [Full Text] [Related]
2. Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging.
Bao X; Wang MW; Zhang YP; Zhang YJ
Biomed Res Int; 2014; 2014():218578. PubMed ID: 24860813
[TBL] [Abstract][Full Text] [Related]
3. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
He S; Wang M; Yang Z; Zhang J; Zhang Y; Luo J; Zhang Y
PLoS One; 2016; 11(7):e0159916. PubMed ID: 27467716
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.
Wu C; Yue X; Lang L; Kiesewetter DO; Li F; Zhu Z; Niu G; Chen X
Theranostics; 2014; 4(5):546-55. PubMed ID: 24672585
[TBL] [Abstract][Full Text] [Related]
6. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
[TBL] [Abstract][Full Text] [Related]
7. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.
Maschauer S; Gahr S; Gandesiri M; Tripal P; Schneider-Stock R; Kuwert T; Ocker M; Prante O
Nucl Med Biol; 2016 Jan; 43(1):27-34. PubMed ID: 26702784
[TBL] [Abstract][Full Text] [Related]
8. FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.
Horn KP; Yap JT; Agarwal N; Morton KA; Kadrmas DJ; Beardmore B; Butterfield RI; Boucher K; Hoffman JM
Cancer Imaging; 2015 Sep; 15(1):15. PubMed ID: 26335224
[TBL] [Abstract][Full Text] [Related]
9. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
[TBL] [Abstract][Full Text] [Related]
10. MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.
Yang G; Nie P; Kong Y; Sun H; Hou G; Han J
Tumour Biol; 2015 May; 36(5):3285-91. PubMed ID: 25501513
[TBL] [Abstract][Full Text] [Related]
11. [
Provost C; Rozenblum-Beddok L; Nataf V; Merabtene F; Prignon A; Talbot JN
Mol Imaging Biol; 2019 Apr; 21(2):297-305. PubMed ID: 29948641
[TBL] [Abstract][Full Text] [Related]
12. Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.
Battle MR; Goggi JL; Allen L; Barnett J; Morrison MS
J Nucl Med; 2011 Mar; 52(3):424-30. PubMed ID: 21321268
[TBL] [Abstract][Full Text] [Related]
13. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model.
Wei YC; Gao Y; Zhang J; Fu Z; Zheng J; Liu N; Hu X; Hou W; Yu J; Yuan S
Sci Rep; 2016 Jun; 6():28757. PubMed ID: 27350554
[TBL] [Abstract][Full Text] [Related]
15. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract][Full Text] [Related]
16. The Distribution Volume of
Roy J; Kuo F; Basuli F; Williams MR; Wong K; Green MV; Seidel J; Adler SS; Xu B; Choyke PL; Jagoda EM
Cancer Biother Radiopharm; 2019 May; 34(4):238-244. PubMed ID: 30767667
[No Abstract] [Full Text] [Related]
17. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
[TBL] [Abstract][Full Text] [Related]
18. PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.
Cai M; Ren L; Yin X; Guo Z; Li Y; He T; Tang Y; Long T; Liu Y; Liu G; Zhang X; Hu S
Amino Acids; 2016 Mar; 48(3):811-820. PubMed ID: 26592497
[TBL] [Abstract][Full Text] [Related]
19. Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment.
Facchin C; Perez-Liva M; Garofalakis A; Viel T; Certain A; Balvay D; Yoganathan T; Woszczyk J; De Sousa K; Sourdon J; Provost J; Tanter M; Lussey-Lepoutre C; Favier J; Tavitian B
Theranostics; 2020; 10(8):3518-3532. PubMed ID: 32206105
[No Abstract] [Full Text] [Related]
20. VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.
Nagengast WB; Lub-de Hooge MN; Oosting SF; den Dunnen WF; Warnders FJ; Brouwers AH; de Jong JR; Price PM; Hollema H; Hospers GA; Elsinga PH; Hesselink JW; Gietema JA; de Vries EG
Cancer Res; 2011 Jan; 71(1):143-53. PubMed ID: 21084271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
